Search results
‘My husband had a stent fitted on holiday – but Co-op won’t pay his £10k hospital bill’
The Telegraph via Yahoo News· 3 days agoSince our return, my husband has been treated by the NHS for obstructive jaundice complicated by ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by UBS Group
ETF DAILY NEWS· 5 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) was downgraded by UBS Group from a “buy” rating to a “neutral” rating in a report issued on Thursday, Briefing.com reports. UBS Group ...
IgG4-Related Disease Affects Men More Often, More Severely
Medscape· 5 days agoA recent study highlighted sex-based differences in manifestations of IgG4-related disease.
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target Cut to $10.00 by Analysts at Stifel Nicolaus
ETF DAILY NEWS· 6 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective reduced by Stifel Nicolaus from $32.00 to $10.00 in a research report report published on Tuesday morning, Benzinga ...
Wells Fargo & Company Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Equal Weight
ETF DAILY NEWS· 6 days agoWells Fargo & Company downgraded shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from an overweight rating to an equal weight rating in a research report report published on Tuesday ...
Ceftazidime is a potential drug to inhibit cell proliferation by increasing cellular p27 - The...
Nature· 6 days agoThe development of new therapeutic uses for existing drugs is important for the treatment of some diseases. Cephalosporin antibiotics stand as the most extensively utilized ...
Oppenheimer Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) Price Target to $25.00
ETF DAILY NEWS· 6 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective trimmed by Oppenheimer from $50.00 to $25.00 in a report issued on Tuesday morning, Benzinga reports. Wells Fargo ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Downgraded by Wedbush
ETF DAILY NEWS· 6 days agoWedbush downgraded shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) from a neutral rating to an underperform rating in a research report sent to investors on Tuesday morning, MarketBeat ...
Zentalis Pharmaceuticals’ (ZNTL) “Hold” Rating Reaffirmed at Jefferies Financial Group
ETF DAILY NEWS· 6 days agoJefferies Financial Group restated their hold rating on shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) in a research report released on Tuesday morning, MarketBeat.com reports ...
Zentalis Pharmaceuticals (NASDAQ:ZNTL) PT Lowered to $20.00 at HC Wainwright
ETF DAILY NEWS· 6 days agoZentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price objective cut by HC Wainwright from $40.00 to $20.00 in a report issued on Tuesday morning, Benzinga reports. Stifel Nicolaus ...